91 related articles for article (PubMed ID: 3279616)
1. The use of OKT3 rescue therapy after orthotopic liver transplantation--the University of Nebraska Medical Center experience.
Wood RP; Shaw BW; Williams L
Transplant Proc; 1988 Feb; 20(1 Suppl 1):254-9. PubMed ID: 3279616
[No Abstract] [Full Text] [Related]
2. Antithymocyte globulin or interleukin 2 receptor antibody for immunosuppressive induction therapy after orthotopic liver transplantation: a follow-up study.
Keck H; Langrehr JM; Knoop M; Lohmann R; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2701. PubMed ID: 8356721
[No Abstract] [Full Text] [Related]
3. [Immunosuppressive treatment after organ transplantation].
Niaudet P
Arch Fr Pediatr; 1988; 45 Suppl 1():741-4. PubMed ID: 3240052
[TBL] [Abstract][Full Text] [Related]
4. Quadruple immunosuppressive therapy for liver transplantation.
Kalayoglu M; Stratta RJ; Hoffmann RM; Sollinger HW; Belzer FO
Transplant Proc; 1988 Feb; 20(1 Suppl 1):524-9. PubMed ID: 3279646
[No Abstract] [Full Text] [Related]
5. Use of antilymphocyte induction therapy in liver transplantation.
Wall WJ
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019
[TBL] [Abstract][Full Text] [Related]
6. Rejection prophylaxis with murine monoclonal CD-3 antibody (OKT3): considerations for early hospital discharge.
Herrick CM; Mealey PC; Hagan ME; Holland CS; Volkman AK; Menlove RL
J Heart Transplant; 1989; 8(1):67-70. PubMed ID: 2647934
[TBL] [Abstract][Full Text] [Related]
7. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F
Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
[No Abstract] [Full Text] [Related]
8. Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial.
Lemmens HP; Langrehr JM; Bechstein WO; Blumhardt G; Keck H; Lüsebrink R; Knoop M; Lohmann R; Tullius S; Lobeck H
Transplant Proc; 1995 Feb; 27(1):1140-1. PubMed ID: 7878826
[No Abstract] [Full Text] [Related]
9. [Immunosuppressive therapy following kidney transplantation].
Seybold D; Gessler U; Sigel A
Urologe A; 1982 Sep; 21(5):274-9. PubMed ID: 6758279
[TBL] [Abstract][Full Text] [Related]
10. [Antilymphocytic serum (antilymphocyte globulin) in the management of transplants].
Gieldanowski J
Wiad Lek; 1970 Nov; 23(22):1971-7. PubMed ID: 4395160
[No Abstract] [Full Text] [Related]
11. Treatment of acute rejection.
Adams DH; Neuberger JM
Semin Liver Dis; 1992 Feb; 12(1):80-8. PubMed ID: 1570553
[No Abstract] [Full Text] [Related]
12. Transplantation 1992: the year in review.
Goodman ER; Hardy MA
Clin Transpl; 1992; ():285-97. PubMed ID: 1306706
[No Abstract] [Full Text] [Related]
13. Immunosuppression induction with daclizumab and antithymocyte globulin in cardiac transplantation: clinical experience with 8 cases.
Huang XS; Chen DZ; Chen LW; Li ZQ; Liao CX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):126-8. PubMed ID: 14965807
[TBL] [Abstract][Full Text] [Related]
14. A new chimeric monoclonal CD4 antibody for prevention of rejection after heart transplantation.
Meiser BM; Reiter C; Ebel M; Uberfuhr P; Wenke K; Reichenspurner H; Rieber E; Riethmüller G; Reichart B
Transplant Proc; 1992 Oct; 24(5):1734. PubMed ID: 1412816
[No Abstract] [Full Text] [Related]
15. OKT3 delays rejection crises after heart transplantation.
Weimar W; Essed CE; Balk AH; Simoons ML; Hendriks GF; Wenting GJ; Mochtar B; Bos E
Transplant Proc; 1989 Feb; 21(1 Pt 3):2497-8. PubMed ID: 2495641
[No Abstract] [Full Text] [Related]
16. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.
Langrehr JM; Guckelberger O; Nüssler N; Radtke A; Lemmens HP; Jonas S; Lohmann R; Tullius S; Steinmüller T; Raakow R; Neumann U; Knoop M; Bechstein WO; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3204. PubMed ID: 8962241
[No Abstract] [Full Text] [Related]
18. Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin.
Lischke R; Simonek J; Davidová R; Schützner J; Stolz AJ; Vojácek J; Burkert J; Pafko P
Transplant Proc; 2007; 39(1):205-12. PubMed ID: 17275507
[TBL] [Abstract][Full Text] [Related]
19. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
[No Abstract] [Full Text] [Related]
20. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
